Authors
Thomas M Drake, Annemarie B Docherty, Ewen M Harrison, Jennifer K Quint, Huzaifa Adamali, Sarah Agnew, Suresh Babu, Christopher M Barber, Shaney Barratt, Elisabeth Bendstrup, Stephen Bianchi, Diego Castillo Villegas, Nazia Chaudhuri, Felix Chua, Robina Coker, William Chang, Anjali Crawshaw, Louise E Crowley, Davinder Dosanjh, Christine A Fiddler, Ian A Forrest, Peter M George, Michael A Gibbons, Katherine Groom, Sarah Haney, Simon P Hart, Emily Heiden, Michael Henry, Ling-Pei Ho, Rachel K Hoyles, John Hutchinson, Killian Hurley, Mark Jones, Steve Jones, Maria Kokosi, Michael Kreuter, Laura S MacKay, Siva Mahendran, George Margaritopoulos, Maria Molina-Molina, Philip L Molyneaux, Aiden O’Brien, Katherine O’Reilly, Alice Packham, Helen Parfrey, Venerino Poletti, Joanna C Porter, Elisabetta Renzoni, Pilar Rivera-Ortega, Anne-Marie Russell, Gauri Saini, Lisa G Spencer, Giulia M Stella, Helen Stone, Sharon Sturney, David Thickett, Muhunthan Thillai, Tim Wallis, Katie Ward, Athol U Wells, Alex West, Melissa Wickremasinghe, Felix Woodhead, Glenn Hearson, Lucy Howard, J Kenneth Baillie, Peter JM Openshaw, Malcolm G Semple, Iain Stewart, R Gisli Jenkins
Publication date
2020/12/15
Journal
American journal of respiratory and critical care medicine
Volume
202
Issue
12
Pages
1656-1665
Publisher
American Thoracic Society
Description
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung disease (ILD) has not been established.
Objectives: To assess outcomes in patients with ILD hospitalized for COVID-19 versus those without ILD in a contemporaneous age-, sex-, and comorbidity-matched population.
Methods: An international multicenter audit of patients with a prior diagnosis of ILD admitted to the hospital with COVID-19 between March 1 and May 1, 2020, was undertaken and compared with patients without ILD, obtained from the ISARIC4C (International Severe Acute Respiratory and Emerging Infection Consortium Coronavirus Clinical Characterisation Consortium) cohort, admitted with COVID-19 over the same period. The primary outcome was survival. Secondary analysis distinguished idiopathic pulmonary fibrosis from non–idiopathic pulmonary fibrosis ILD and used lung function to determine the …
Scholar articles
TM Drake, AB Docherty, EM Harrison, JK Quint… - American journal of respiratory and critical care …, 2020